Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
6
FDA:6
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
- First Posted Date
- 2016-08-05
- Last Posted Date
- 2017-03-15
- Lead Sponsor
- Cardinal Health 414, LLC
- Registration Number
- NCT02857608
A Study of Lymphoseek® as a Lymphoid Tissue Targeting Agent in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Phase 2
Completed
- Conditions
- RhabdomyosarcomaMelanoma
- Interventions
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2024-06-28
- Lead Sponsor
- Cardinal Health 414, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT02509598
- Locations
- 🇺🇸
Nemours Children's Specialty Care, Jacksonville, Florida, United States
🇺🇸Nemours Children's Hopsital, Orlando, Florida, United States
🇺🇸Children's Hospital Medical Center, Cincinnati, Ohio, United States
A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
- First Posted Date
- 2015-07-28
- Last Posted Date
- 2019-02-11
- Lead Sponsor
- Cardinal Health 414, LLC
- Target Recruit Count
- 18
- Registration Number
- NCT02509585
- Locations
- 🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸Sylvester Comprehensive Cancer Center, Miami, Florida, United States
🇺🇸Wake Forest Baptist Health, Winston-Salem, North Carolina, United States
News
No news found